Skip to main content
Home / Current Medicinal Chemistry, Volume 9, Number 21
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 21, 2002

Review article

Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
pp. 1851-1858(8)
Authors: Gridelli, C.; Maione, P.; Airoma, G.; Rossi, A.

Favourites:
ADD

BM 212 and its Derivatives as a New Class of Antimycobacterial Active Agents
pp. 1859-1869(11)
Author: Biava, M.

Favourites:
ADD

Drug Evolution: p-Aminobenzoic Acid as a Building Block
pp. 1871-1892(22)
Authors: Kluczyk, A.; Popek, T.; Kiyota, T.; de Macedo, P.; Stefanowicz, P.; Lazar, C.; Konishi, Y.

Favourites:
ADD

The Role of Monocytes and Macrophages in the Pathogenesis of HIV-1 Infection
pp. 1893-1903(11)
Authors: Kedzierska, K.; Crowe, S.M.

Favourites:
ADD

HIV Protease Inhibitors: Peptidomimetic Drugs and Future Perspectives
pp. 1905-1922(18)
Authors: Abdel-Rahman, H.M.; Al-karamany, G.S.; El-Koussi, N.A.; Youssef, A.F.; Kiso, Y.

Favourites:
ADD

Adenosine A1 Receptor: Analysis of the Potential Therapeutic Effects Obtained by its Activation in the Central Nervous System
pp. 1923-1937(15)
Authors: Dalpiaz, A.; Manfredini, S.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content